STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

December 19, 2022

Period of Report

December 19, 2022

Accession Number

0001062993-22-024173